Devoro Medical
Fremont, US · Founded 2017 · Delaware corporation · 55,131 employees on LinkedIn · 3 known investors
Find your way into Devoro Medical
Sign up to see every warm intro you have to Devoro Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Devoro Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Devoro Medical developed the WOLF Thrombectomy Platform, a non-console, lytic-free medical device that uses finger-like prongs to capture and remove blood clots (thrombi) from the arterial and venous systems. The technology serves physicians performing thrombectomy procedures for clot management.
Founders & leadership
Board

Investors · 3
How we know: APERTURE Venture Partners's portfolio page · Not right? Tell us
How we know: ShangBay Capital LLC's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$26.5M disclosed across 2 rounds · 2019–2020
▶$18MraisedJul 2020 · 6 investors · OtherRule 506(b)
- Skott GreenhalghDirector
- Casper de ClercqDirector
- Michael WallaceExecutive Officer, Director
- Erik EngelsonDirector
- Offering amount
- $18M
- Amount sold
- $18M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$8.5MraisedAug 2019 · 16 investors · OtherRule 506(b)
- Erik EngelsonDirector
- Skott GreenhalghDirector
- Michael WallaceExecutive Officer, Director
- Offering amount
- $8.5M
- Amount sold
- $8.5M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Devoro Medical do?
- Devoro Medical developed the WOLF Thrombectomy Platform, a non-console, lytic-free medical device that uses finger-like prongs to capture and remove blood clots (thrombi) from the arterial and venous systems. The technology serves physicians performing thrombectomy procedures for clot management.
- Who are Devoro Medical's investors?
- Devoro Medical's investors include APERTURE Venture Partners, ShangBay Capital LLC, Norwest Venture Partners.
- How much funding has Devoro Medical raised?
- Devoro Medical has disclosed $26.5M raised across 2 rounds.
- Where is Devoro Medical headquartered?
- Devoro Medical is headquartered in Fremont, US.

